Explore >> Select a destination
|
You are here 
|
psychology.uga.edu | ||
| | | | |
qualiacomputing.com
|
|
| | | | | Excerpts fromUnifying Theories of Psychedelic Drug Effects(2018) by Link Swanson(these are just key quotes; the full paper is worth reading) Abstract How do psychedelic drugs produce their characteristic range of acute effects in perception, emotion, cognition, and sense of self? How do these effects relate to the clinical efficacy of psychedelic-assisted therapies? Efforts to understand... | |
| | | | |
www.yalemedicine.org
|
|
| | | | | Dr. Sanacora is a Professor of Psychiatry at Yale University and the Director of the Yale Depression Research Program. Dr. Sanacora's work has focused largely on elucidating the pathophysiological mechanisms associated with mood and other neuropsychiatric disorders and using this information to inform the development of novel treatment strategies. His preclinical research laboratory explores the effects of stress and pharmaceutical agents on cellular biology, neurophysiology and behavior. His clinical la... | |
| | | | |
psyc.franklin.uga.edu
|
|
| | | | | The Neuroscience group within the Behavior and Brain Sciences (BBS) area of the Psychology department includes a diversity of interdisciplinary approaches to the study of the biological basis of mental phenomena and clinical disorders. Topics of research range from microscopic neurochemical processes to thefunctional organization of large scale cerebral systems. We have extensive expertise in the fields ofBehavioral Neuroscience, Clinical Neuroscience, Cognitive Neuroscience and Social / Affective Neuros... | |
| | | | |
www.cleveland.com
|
|
| | | The Akron health system cites resource drain and patient protection as reasons behind the policy change as it finalizes its $485 million sale to a private equity firm | ||
